Type i interferon-mediated autoinflammation due to DNase II deficiency

Nature Communications

Volumn 8, Issue 1, 2017, Pages

  Rodero, Mathieu P ^a   Tesser, Alessandra ^b   Bartok, Eva ^c   Rice, Gillian I ^d   Della Mina, Erika ^a   Depp, Marine ^a   Beitz, Benoit ^e   Bondet, Vincent ^f,g   Cagnard, Nicolas ^h   Duffy, Darragh ^f,g   Dussiot, Michael ⁱ   Frémond, Marie Louise ^a   Gattorno, Marco ^j   Guillem, Flavia ⁱ   Kitabayashi, Naoki ^a   Porcheray, Fabrice ^e   Rieux Laucat, Frederic ^a,h   Seabra, Luis ^a   Uggenti, Carolina ^a   Volpi, Stefano ^j   Zeef, Leo A H ^k   Alyanakian, Marie Alexandra ^l   Beltrand, Jacques ^l,m   Bianco, Anna Monica ⁿ   Boddaert, Nathalie ^i,l   Brouzes, Chantal ^l   Candon, Sophie ^l   Caorsi, Roberta ^j   Charbit, Marina ^l   Fabre, Monique ^l   Faletra, Flavio ⁿ   Girard, Muriel ^i,l   Harroche, Annie ^l   Hartmann, Evelyn ^c,o   Lasne, Dominique ^l,p   Marcuzzi, Annalisa ^b   Neven, Bénédicte ^a,h,l   Nitschke, Patrick ^h,i   Pascreau, Tiffany ^l,p   Pastore, Serena ⁿ   Picard, Capucine ^i,l,q   Picco, Paolo ^j   Piscianz, Elisa ^b   Polak, Michel ^l,m   Quartier, Pierre ^a,h,l   Rabant, Marion ^l   Stocco, Gabriele ^b   Taddio, Andrea ^b,n   Uettwiller, Florence ^a,h,l   Valencic, Erica ⁿ   Vozzi, Diego ⁿ   Hartmann, Gunther ^c   Barchet, Winfried ^c,r   Hermine, Olivier ^i,s   Bader Meunier, Brigitte ^a,l   Tommasini, Alberto ⁿ   Crow, Yanick J ^a,d,h,l   more..

^a INSERM   (France)

^b UNIVERSITY OF TRIESTE   (Italy)

^c UNIVERSITY OF BONN   (Germany)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e BIOASTER   (France)

^f INSTITUT PASTEUR   (France)

^g INSTITUT PASTEUR   (France)

^h UNIVERSITÉ PARIS DESCARTES   (France)

ⁱ IMAGINE INSTITUTE   (France)

^j G GASLINI INSTITUTE   (Italy)

^k UNIVERSITY OF MANCHESTER   (United Kingdom)

^l HÔPITAL NECKER ENFANTS MALADES   (France)

^m INSTITUT COCHIN   (France)

ⁿ INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^o UNIVERSITY HOSPITAL BONN   (Germany)

^p Dept Environ Med Natl Inst Publ HIth   (Norway)

^q Necker Medical School   (France)

^r German Center for Infection Research (DZIF)   (Germany)

^s ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; DEOXYRIBONUCLEASE II; DNA ANTIBODY; INTERFERON; RNA; STAT1 PROTEIN; STAT3 PROTEIN; ANTIVIRUS AGENT; DEOXYRIBONUCLEASE; MESSENGER RNA; STAT1 PROTEIN, HUMAN; STAT3 PROTEIN, HUMAN;

ANTIBODY; BLOOD; CELLS AND CELL COMPONENTS; DISEASE INCIDENCE; ENZYME; ENZYME ACTIVITY; GENE; GENE EXPRESSION; HEMATOLOGY; MUTATION; NUCLEIC ACID; PROTEIN;

ADOLESCENT; ARTHROPATHY; ARTICLE; CASE REPORT; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEOXYRIBONUCLEASE II DEFICIENCY; ENZYME ACTIVITY; ENZYME DEFICIENCY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROBLAST; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC VARIABILITY; HEMATOLOGIC DISEASE; HUMAN; HUMAN CELL; INFLAMMATION; LIVER FIBROSIS; LYMPHOCYTE; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MONOCYTE; NEWBORN ANEMIA; PHENOTYPE; PROTEIN PHOSPHORYLATION; RNA ANALYSIS; RNA SEQUENCE; SCHOOL CHILD; SIBLING; TRANSCRIPTOMICS; UPREGULATION; BLOOD; DEFICIENCY; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION PROFILING; GENETICS; HEMATOPOIESIS; HEREDITARY PERIODIC FEVER; IMMUNOLOGY; METABOLISM; MUTATION; PHOSPHORYLATION; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION;

ADOLESCENT; ANTIVIRAL AGENTS; CHILD; ENDODEOXYRIBONUCLEASES; ERYTHROBLASTS; FEMALE; GENE EXPRESSION PROFILING; HEMATOPOIESIS; HEREDITARY AUTOINFLAMMATORY DISEASES; HUMANS; INTERFERON-ALPHA; MALE; MUTATION; PHOSPHORYLATION; RNA, MESSENGER; SEQUENCE ANALYSIS, RNA; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; UP-REGULATION;

EID: 85038631017     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-017-01932-3     Document Type: Article

References (53)

1. Janeway, C. A. Jr. Approaching the asymptote Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 54, 1-13 (1989)
2. Hartmann, G. Nucleic acid immunity. Adv. Immunol. 133, 121-169 (2017)
3. Crowl, J. T., Gray, E. E., Pestal, K., Volkman, H. E. & Stetson, D. B. Intracellular nucleic acid detection in autoimmunity. Annu. Rev. Immunol. 35, 313-336(2017)
4. Schlee, M. & Hartmann, G. Discriminating self from non-self in nucleic acid sensing. Nat. Rev. Immunol. 16, 566-580 (2016)
5. Roers, A., Hiller, B. & Hornung, V. Recognition of endogenous nucleic acids by the innate immune system. Immunity 44, 739-754 (2016)
6. Crow, Y. J. Type I interferonopathies: A novel set of inborn errors of immunity. Ann. NY Acad. Sci. 1238, 91-98 (2011)
7. Rodero, M. P. & Crow, Y. J. Type I interferon-mediated monogenic autoinflammation: The type I interferonopathies, a conceptual overview. J. Exp. Med. 213, 2527-2538 (2016)
8. Crow, Y. J. et al. Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 cause Aicardi-Goutieres syndrome at the AGS1 locus. Nat. Genet. 38, 917-920 (2006)
9. Stetson, D. B., Ko, J. S., Heidmann, T. & Medzhitov, R. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 134, 587-598 (2008)
10. Ahn, J., Ruiz, P. & Barber, G. N. Intrinsic self-DNA triggers inflammatory disease dependent on STING. J. Immunol. 193, 4634-4642 (2014)
11. Gray, E. E., Treuting, P. M., Woodward, J. J. & Stetson, D. B. Cutting Edge: cGAS is required for lethal autoimmune disease in the Trex1-deficient mouse model of aicardi-goutieres syndrome. J. Immunol. 195, 1939-1943 (2015)
12. Gao, D. et al. Activation of cyclic GMP-AMP synthase by self-DNA causes autoimmune diseases. Proc. Natl Acad. Sci. USA 112, E5699-E5705 (2015)
13. Rice, G. I. et al. Assessment of interferon-related biomarkers in Aicardi-Goutieres syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: A case-control study. Lancet. Neurol. 12, 1159-1169 (2013)
14. Rice, G. I. et al. Assessment of Type I interferon signaling in pediatric inflammatory disease. J. Clin. Immunol. 37, 123-132 (2017)
15. Kawane, K., Motani, K. & Nagata, S. DNA degradation and its defects. Cold Spring Harb. Perspect. Biol. 6, a016394 (2014)
16. Cartegni, L., Chew, S. L. & Krainer, A. R. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat. Rev. Genet. 3, 285-298 (2002)
17. Schafer, P., Cymerman, I. A., Bujnicki, J. M. & Meiss, G. Human lysosomal DNase IIalpha contains two requisite PLD-signature (HxK) motifs: evidence for a pseudodimeric structure of the active enzyme species. Protein Sci. 16, 82-91 (2007)
18. Kawane, K. et al. Requirement of DNase II for definitive erythropoiesis in the mouse fetal liver. Science 292, 1546-1549 (2001)
19. Krieser, R. J. et al. Deoxyribonuclease IIalpha is required during the phagocytic phase of apoptosis and its loss causes perinatal lethality. Cell Death Differ. 9, 956-962 (2002)
20. Yoshida, H., Okabe, Y., Kawane, K., Fukuyama, H. & Nagata, S. Lethal anemia caused by interferon-beta produced in mouse embryos carrying undigested DNA. Nat. Immunol. 6, 49-56 (2005)
21. Kawane, K. et al. Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages. Nature 443, 998-1002 (2006)
22. Kawane, K., Tanaka, H., Kitahara, Y., Shimaoka, S. & Nagata, S. Cytokine-dependent but acquired immunity-independent arthritis caused by DNA escaped from degradation. Proc. Natl Acad. Sci. USA 107, 19432-19437 (2010)
23. Ahn, J., Gutman, D., Saijo, S. & Barber, G. N. STING manifests self DNA-dependent inflammatory disease. Proc. Natl Acad. Sci. USA 109, 19386-19391 (2012)
24. Meyer, S. et al. AIRE-deficient patients harbor unique high-affinity disease-ameliorating autoantibodies. Cell 166, 582-595 (2016)
25. Rissin, D. M. et al. Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations. Nat. Biotechnol. 28, 595-599 (2010)
26. Rodero, M. P. et al. Detection of interferon alpha protein reveals differential levels and cellular sources in disease. J. Exp. Med. 214, 1547-1555 (2017)
27. Yoshida, H. et al. Phosphatidylserine-dependent engulfment by macrophages of nuclei from erythroid precursor cells. Nature 437, 754-758 (2005)
28. Chasis, J. A. & Mohandas, N. Erythroblastic islands: niches for erythropoiesis. Blood 112, 470-478 (2008)
29. Evans, C. J. & Aguilera, R. J. DNase II: genes, enzymes and function. Gene 322, 1-15 (2003)
30. Nagata, S. & Kawane, K. Autoinflammation by endogenous DNA. Adv. Immunol. 110, 139-161 (2011)
31. Okabe, Y., Kawane, K. & Nagata, S. IFN regulatory factor (IRF) 3/7-dependent and-independent gene induction by mammalian DNA that escapes degradation. Eur. J. Immunol. 38, 3150-3158 (2008)
32. Rice, G. et al. Clinical and molecular phenotype of Aicardi-Goutieres syndrome. Am. J. Hum. Genet. 81, 713-725 (2007)
33. Meuwissen, M. E. et al. Human USP18 deficiency underlies type 1 interferonopathy leading to severe pseudo-TORCH syndrome. J. Exp. Med. 213, 1163-1174 (2016)
34. Binder, D., Fehr, J., Hengartner, H. & Zinkernagel, R. M. Virus-induced transient bone marrow aplasia: major role of interferon-alpha/beta during acute infection with the noncytopathic lymphocytic choriomeningitis virus. J. Exp. Med. 185, 517-530 (1997)
35. de Carvalho, L. M. et al. Musculoskeletal disease in MDA5-related type I interferonopathy: A Mendelian mimic of Jaccoud's arthropathy. Arthritis Rheumatol. 69, 2081-2091 (2017)
36. Hooks, J. J. et al. Immune interferon in the circulation of patients with autoimmune disease. N. Engl. J. Med. 301, 5-8 (1979)
37. Napirei, M. et al. Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat. Genet. 25, 177-181 (2000)
38. Lee-Kirsch, M. A. et al. Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat. Genet. 39, 1065-1067 (2007)
39. Al-Mayouf, S. M. et al. Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus. Nat. Genet. 43, 1186-1188 (2011)
40. Sisirak, V. et al. Digestion of chromatin in apoptotic cell microparticles prevents autoimmunity. Cell 166, 88-101 (2016)
41. Isaacs, A., Cox, R. A. & Rotem, Z. Foreign nucleic acids as the stimulus to make interferon. Lancet 2, 113-116 (1963)
42. Fremond, M. L. et al. Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 children. J. Allergy Clin. Immunol. 138, 1752-1755 (2016)
43. Fremond, M. L. et al. Brief report: blockade of TANK-binding kinase 1/IKKvarepsilon Inhibits mutant stimulator of interferon genes (STING)-mediated inflammatory responses in human peripheral blood mononuclear cells. Arthritis Rheumatol. 69, 1495-1501 (2017)
44. Junt, T. & Barchet, W. Translating nucleic acid-sensing pathways into therapies. Nat. Rev. Immunol. 15, 529-544 (2015)
45. Gibson, D. G. et al. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat. Methods 6, 343-345 (2009)
46. Kutner, R. H., Zhang, X. Y. & Reiser, J. Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors. Nat. Protoc. 4, 495-505 (2009)
47. Maelfait, J., Bridgeman, A., Benlahrech, A., Cursi, C. & Rehwinkel, J. Restriction by SAMHD1 limits cGAS/STING-dependent innate and adaptive immune responses to HIV-1. Cell Rep. 16, 1492-1501 (2016)
48. Howell, D. P., Krieser, R. J., Eastman, A. & Barry, M. A. Deoxyribonuclease II is a lysosomal barrier to transfection. Mol. Ther. 8, 957-963 (2003)
49. Kunitz, M. Crystalline desoxyribonuclease; isolation and general properties; spectrophotometric method for the measurement of desoxyribonuclease activity. J. Gen. Physiol. 33, 349-362 (1950)
50. Gao, P. et al. Structure-function analysis of STING activation by c[G(2′,5′)pA(3′,5′)p] and targeting by antiviral DMXAA. Cell 154, 748-762 (2013)
51. Schlee, M. et al. Recognition of 5′ triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity 31, 25-34 (2009)
52. Arlet, J. B. et al. HSP70 sequestration by free alpha-globin promotes ineffective erythropoiesis in beta-thalassaemia. Nature 514, 242-246 (2014)
53. MacLea, K. S., Krieser, R. J. & Eastman, A. Structural requirements of human DNase II alpha for formation of the active enzyme: the role of the signal peptide, N-glycosylation, and disulphide bridging. Biochem. J. 371, 867-876 (2003).